Clinical trial

Safinamide for Levodopa-induced Dyskinesia (PD-LID)

NCT03987750

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2019-10-01

PhasePHASE3

Study timeline

Study start (estimated)2019-10-01Date precision: month

Registry last updated2020-06-17

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Dyskinesia, Drug-Inducedunresolved

Parkinson Diseaseunresolved

Interventions

Safinamide Methanesulfonate 150mgDRUG

Safinamide Methanesulfonate 100mgDRUG

Safinamide Methanesulfonate matching placeboDRUG

Sponsors & collaborators

Zambon SpAlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03987750 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.